Eugene Myron Holuka - 12 Aug 2024 Form 4 Insider Report for CITIUS ONCOLOGY, INC. (CTOR)

Role
Director
Signature
/s/ Lorna A. Knick, by Power of Attorney
Issuer symbol
CTOR
Transactions as of
12 Aug 2024
Net transactions value
$0
Form type
4
Filing time
16 Aug 2024, 16:06:41 UTC
Previous filing
30 Aug 2024
Next filing
12 Nov 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTOR Stock Option (Right to Buy) Award $0 +150,000 $0.000000 150,000 12 Aug 2024 Common Stock 150,000 $2.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option, originally issued by Citius Oncology Sub, Inc., is 100% vested. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024.